Per-goran Gillberg
Stockholm, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Spiral volumetric optoacoustic tomography of reduced oxygen saturation in the spinal cord of M83 mouse model of Parkinson's disease.
Journal: European journal of nuclear medicine and molecular imaging
Published: June 25, 2024
Correction: Discriminative binding of tau PET tracers PI2620, MK6240 and RO948 in Alzheimer's disease, corticobasal degeneration and progressive supranuclear palsy brains.
Journal: Molecular psychiatry
Published: March 08, 2023
A3907, a systemic ASBT inhibitor, improves cholestasis in mice by multiorgan activity and shows translational relevance to humans.
Journal: Hepatology (Baltimore, Md.)
Published: September 28, 2022
Discriminative binding of tau PET tracers PI2620, MK6240 and RO948 in Alzheimer's disease, corticobasal degeneration and progressive supranuclear palsy brains.
Journal: Molecular psychiatry
Published: May 18, 2022
Impact of elobixibat on serum and fecal bile acid levels and constipation symptoms in patients with chronic constipation.
Journal: Journal of gastroenterology and hepatology
Published: September 15, 2021
Effects of odevixibat on pruritus and bile acids in children with cholestatic liver disease: Phase 2 study.
Journal: Clinics and research in hepatology and gastroenterology
Published: October 14, 2020
Systematic Review and Meta-analysis: Partial External Biliary Diversion in Progressive Familial Intrahepatic Cholestasis.
Journal: Journal of pediatric gastroenterology and nutrition
Published: May 21, 2020
Amyloid, tau, and astrocyte pathology in autosomal-dominant Alzheimer's disease variants: AβPParc and PSEN1DE9.
Journal: Molecular psychiatry
Published: February 29, 2020
Efficacy, long-term safety, and impact on quality of life of elobixibat in more severe constipation: Post hoc analyses of two phase 3 trials in Japan.
Journal: Neurogastroenterology and motility
Published: November 19, 2018
Tau PET imaging in neurodegenerative tauopathies-still a challenge.
Journal: Molecular psychiatry
Published: July 18, 2018
Safety and efficacy of elobixibat for chronic constipation: results from a randomised, double-blind, placebo-controlled, phase 3 trial and an open-label, single-arm, phase 3 trial.
Journal: The lancet. Gastroenterology & hepatology
Published: February 20, 2018
Comparative binding properties of the tau PET tracers THK5117, THK5351, PBB3, and T807 in postmortem Alzheimer brains.
Journal: Alzheimer's research & therapy
Published: July 06, 2017
Last Updated: 09/26/2026